| DATE | POST |
|---|---|
| Nov 16, 2017 |
Aurora BioPharma Announces Participation at the Scientific Meeting and Education Day of the Society for Neuro-Oncology
CAMBRIDGE, MA, November 16, 2017 – Aurora BioPharma announces attendance at the 22nd Annual Scientific Meeting and Education Day of the Society for Neuro-Oncology taking place November 16 -19th at the Marriott Marquis in San Francisco.
|
| Nov 15, 2017 |
Aurora BioPharma CEO to Attend RESI NYC 2017
CAMBRIDGE, MA, November 15, 2017 – The CEO of Aurora BioPharma, Robert Brooks, will attend the Redefining Early Stage Investments (RESI) Conference on November 15, 2017 at the New York Marriott Marquis.
|
| Nov 9, 2017 |
Aurora BioPharma Announces Attendance at the NYC Life Science Conference
CAMBRIDGE, MA, November 9, 2017 -- The CEO of Aurora BioPharma, Robert Brooks, will attend the NYC Life Science Conference by ivyFON and Wheaton Ventures on November 9 – 10 at the W.R. Grace Building in New York City. The event attracts over 80 investors and 25 presenting companies, and features numerous informative panels.
|
| Sept 26, 2017 |
Aurora BioPharma Attends the 17th Annual Biotech in Europe Forum at the Congress Center Basel in Basel, Switzerland
Cambridge, MA, September 26, 2017-- Aurora BioPharma, Inc. announces its CEO, Robert Brooks, will attend the 17th Annual Biotech in Europe Forum for Global Partnering & Investment taking place September 26th - 27th, 2017 at the Congress Center Basel in Basel, Switzerland for partnering sessions.
|
| Sept 13, 2017 |
Aurora BioPharma Chosen for Innovation Challenge at RESI Boston 2017
Cambridge, MA, September 13, 2017-- Aurora BioPharma is one of 40 companies selected from a pool of over 100 applicants to compete in the Life Science Nation's RESI Innovation Challenge on September 26, 2017 in Boston. The event will take at the Boston Marriott Copley Place on September 26, 2017. The conference attracts attendees from the U.S. and 25 other countries. They include qualified investors or strategic partners, scientists, and C-Level Executives from emerging companies in the biopharmaceutical and biotechnology sectors.
|
| June 16, 2017 |
Aurora BioPharma to Present at the 2017 BIO International Convention
Cambridge, MA, June 16, 2017 -- Aurora BioPharma, Inc., a clinical stage biotechnology company
developing genetically reprogrammed T Cell therapy to treat Solid and Liquid tumors,
announced today that company CEO and President, Robert Brooks, will present at the 2017 BIO
International Convention taking place at the San Diego Convention Center June 19 – 22.
|
| May 10, 2017 |
Aurora BioPharma to Attend the New York BIO 2017 Annual Conference 10 on the Park @ Time Warner Center in Columbus Circle
Cambridge, MA, May 10, 2017 -- Aurora BioPharma, Inc., a clinical stage biotechnology company
developing a breakthrough in cancer treatment, announced today that company CEO and President, Robert
Brooks, will attend the New York BIO 2017 Annual Conference taking place May 10-11, at 10 on the Park @
Time Warner Center in Columbus Circle. The event attracts a global audience including attendees from
Europe and Asia. The conference brings together emerging and established companies, investors,
business development professionals, and scientists advancing life science discoveries.
|
| April 27, 2017 |
Aurora BioPharma to Attend Pioneers 2017 at the
Mandarin Oriental Hotel in New York
Cambridge, MA, April 27, 2017 -- Aurora BioPharma, Inc., a clinical stage biotechnology company
developing a breakthrough in cancer treatment, announced today that company CEO and President, Robert
Brooks, will attend Pioneers 2017 presented by Joseph Gunnar & Co., LLC taking place Tuesday May
2nd at the Mandarin Oriental Hotel in New York.
|
| April 8, 2017 |
Aurora BioPharma To Join In On A Presentation And Discussion On The GBM AGILE Trial At The Ritz-Carlton, Pentagon City
Cambridge, MA, April 8, 2017 -- Aurora BioPharma, Inc., a clinical stage biotechnology company
developing a breakthrough in cancer treatment, announced today that company CEO and President, Robert
Brooks, will join in on a presentation and discussion of the GBM AGILE (Adaptive, Global, Innovative,
Learning Environment) trial. The meeting is being held at the Ritz Carlton, at Fashion Centre at Pentagon
City, April 11th.
|
| April 4, 2017 |
Aurora BioPharma to Attend the Needham & Company's 16th Annual Healthcare Conference
|
| March 15, 2017 |
Aurora BioPharma to Attend the Oppenheimer & Co. 27th Annual Healthcare Conference at the Westin New York Grand Central in New York City
Cambridge, MA, March 15, 2017 -- Aurora BioPharma, Inc., a clinical stage biotechnology company
developing CAR T Cell Therapy to treat Solid and Liquid tumors, announced today that company CEO and
President, Robert Brooks, will attend the Oppenheimer & Co. 27th Annual Healthcare Conference on March
21-22, 2017 at The Westin New York Grand Central in New York City. The event is one of the most
important investor conferences in the healthcare industry. Investors will have access to and be able to gain
insight from key thought leaders from public and private companies spanning all major sectors: bio &
specialty pharmaceuticals; medical devices; healthcare facilities; life science tools and diagnostics;
healthcare information technology and distribution, and healthcare providers. Company executives will
address topical issues such as health reform; generic drug regulation; development of new pharmaceutical
and biotechnology products; product safety, patent issues and Food and Drug Administration policy.
|
| March 14, 2017 |
Aurora BioPharma to Attend the Rodman & Renshaw
"A Future Without Cancer" Conference on Friday, March 17, 2017
CAMBRIDGE, MA, March 14, 2017 -- Aurora BioPharma, Inc. a clinical stage biotechnology company
developing CAR T Cell Therapy to treat Solid and Liquid tumors, announced today that company CEO and
President, Robert Brooks, will attend "A Future Without Cancer," a Rodman & Renshaw Premier Series
conconference being held on Friday, March 17, 2017.
|
| March 13, 2017 |
Aurora BioPharma to Attend 29th Annual ROTH Conference at the Ritz-Carlton, Laguna Niguel in Dana Point, CA
CAMBRIDGE, MA, March 13, 2017 -- Aurora BioPharma, a clinical stage biotechnology company,
developing genetically programmed CAR T Cell Therapy to treat Liquid and Solid tumors, will attend the
29th Annual ROTH Conference on March 13, 2017 at the Ritz Carlton, Laguna Niguel, in Dana Point, CA.
Robert Brooks, President and CEO, will be available for one-on-one meetings.
|
| January 8, 2017 |
Aurora BioPharma Attends the 2017 J.P. Morgan Healthcare Conference
CAMBRIDGE, MA, January 8, 2017 -- Aurora BioPharma, Inc. attends the 35th Annual J.P. Morgan
Healthcare Conference taking place January 9-12, 2017 at the Westin St. Francis Hotel in San Francisco,
California.
|
| Sept 26, 2016 |
Aurora BioPharma to Attend Ladenburg Thalmann’s Healthcare Conference
CAMBRIDGE, MA,September 26, 2016 -- Aurora BioPharma, Inc. will attend Ladenburg Thalmann's 2016
Healthcare Conference Tuesday, September 27th at the Sofitel New York hotel. The day event will feature
corporate presentations and pre-scheduled meetings.
|
| Sept 15, 2016 |
Aurora BioPharma CEO to Present at the Aegis Capital Corp. 2016 Growth Investment Conference
CAMBRIDGE, MA, September 15, 2016 -- Aurora BioPharma, Inc., CEO, Robert Brooks, will present at the
Aegis Capital Corp. 2016 Growth Investment Conference taking place at the Encore at Wynn Las Vegas
September 20-22.
|
| Sept 13, 2016 |
Aurora BioPharma CEO to Present at the 15TH Annual BIO Investor Forum
CAMBRIDGE, MA, September 13, 2016 -- Aurora BioPharma, Inc. is pleased to announce that our CEO,
Robert Brooks, will present at the 15th Annual BIO Investor Forum, a gathering attracting more than 900
private equity and public investors, research analysts, and industry executives participating in some 1,700
meetings and 175 public and venture stage company presentations. The event will take place October 18-
19 at the Westin St. Francis Hotel in San Francisco.
|
| Sept 9, 2016 |
Aurora BioPharma to Attend the 5TH Annual
OctoberINVESTfest Conference at the World Trade Center 7
CAMBRIDGE, MA, September 9, 2016 -- The CEO of Aurora BioPharma, Robert Brooks, will attend
OktoberINVESTfest, the 5th Annual Investors Conference to be held once again at The New York Academy
of Sciences, World Trade Center 7, on September 28, 2016. The building is one of New York's LEED-
certified green buildings, representative of Bavaria's Energy Turn Around initiatives. This year's program will
feature distinguished panelists and speakers complimented by power networking at the "Unconference
Luncheon".
|
| Sept 7, 2016 |
Aurora BioPharma to Attend the Rodman & Renshaw 18th Annual
Global Investment Conference at the New York Palace Hotel
CAMBRIDGE, MA, September 7, 2016 -- The CEO of Aurora BioPharma, Inc., Robert Brooks, will attend
the Rodman & Renshaw 18th Annual Global Investment Conference being held at the New York Palace
Hotel in New York City on September 11 - 13, 2016. The conference is expected to attract an audience of
2,000 attendees from the financial, investment and corporate arenas. Keynote Speakers are The Right
Honourable Sir John Major KG CH, former Prime Minister of the United Kingdom and Jeb Bush,
43rd Governor of Florida.
|
| Sept 7, 2016 |
Aurora BioPharma to Attend the 23rd Annual NewsMakers in the Biotech Industry Conference
CAMBRIDGE, MA, September 7, 2016 -- The CEO of Aurora BioPharma, Inc., Robert Brooks, will attend
the 23rd annual NewsMakers in the Biotech Industry Conference to be held at the Millennium Broadway
Hotel and Conference Center in New York, September 9th, 2016.
|
| May 27, 2016 |
Aurora BioPharma to present at the Fifth Annual Marcum Microcap Conference
CAMBRIDGE, MA - May 27, 2016 - Aurora BioPharma, a company commercializing cutting-edge cancer adoptive cell immunotherapy, with CAR T cells in liquid and solid tumors, announced today its CEO, Robert Brooks, will attend the 5th Annual Marcum MicroCap Conference on June 1-2, 2016 in New York City at the Grand Hyatt Hotel.
|
| May 26, 2016 |
Aurora BioPharma to Present at the 2016 BIO International Convention
CAMBRIDGE, MA -May 26, 2016- Aurora BioPharma announced that its CEO, Robert Brooks, will be presenting at the 2016 BIO International Convention taking place June 6-9, 2016 at the Moscone Center in San Francisco, California.
|
| April 30, 2016 |
Aurora BioPharma CEO Joins Dignitaries During AANS Annual Scientific Meeting in Chicago
CAMBRIDGE, MA -May 26, 2016- Aurora BioPharma announced that its CEO, Robert Brooks, will be presenting at the 2016 BIO International Convention taking place June 6-9, 2016 at the Moscone Center in San Francisco, California.
|
| April 4, 2016 |
Aurora BioPharma CEO to Present Cutting-Edge Cancer Fighting Technology at BIO-Europe Spring in Stockholm, Sweden
CAMBRIDGE, MA - April 4, 2016 - The CEO of Aurora BioPharma, Inc., Robert Brooks, will present the newest technology based on cutting-edge immunotherapy to kill cancer, at the tenth annual BIO-Europe Spring international life science partnering conference to be held in Stockholm, Sweden, April 4 - 6, 2016. Organized by EBD Group, the event is a world class gathering attracting over 2,000 life science executives. It is co-hosted by Stockholm Business Region and Stockholm Science City Foundation.
|
| April 1, 2016 |
The CEO of Aurora BioPharma is a Featured Guest on CBS in a Discussion on Cancer Research in Pediatrics
CAMBRIDGE, MA - April 1, 2016 - Aurora BioPharma, Inc. CEO, Robert Brooks, is joined by Raymond Rodriguez-Torres, Chairman of the “Live Like Bella” Childhood Cancer Foundation on the set of CBS Miami public affairs show “Focus On South Florida”, hosted by Rudabeh Shahbazi. The panelists discussed the newest research aimed at finding a cure for pediatric cancer. Organizers urged Congress to enact the “Bella Bill” – legislation focusing on cancer research in pediatrics – following resolutions passed by City of Miami and Miami-Dade County commissioners in support of the bill.
|
| April 1, 2016 |
CBS Miami Focus on South Florida Pediatric Cancer:
http://miami.cbslocal.com/2016/04/03/focus-on-south-florida-pediatric-cancer-research/
|
| February 9, 2016 |
Medcity News: Aurora Biopharma tackling glioblastoma with CAR-T immunotherapy
http://medcitynews.com/2016/02/aurora-glioblastoma-immunotherapy/
|
| January 26, 2016 |
Aurora BioPharma, Inc. To Present CAR T Cell Therapy Clinical Data In Solid Tumors at BIO CEO and Investor
CAMBRIDGE, MA – January 26, 2016 – Aurora BioPharma, Inc. CEO, Robert Brooks, will present promising CAR T Cell Therapy data in Solid Tumor from FDA Phase I Clinical trials in Glioblastoma and Sarcoma at the 18th Annual BIO CEO & Investor Conference taking place February 8-9, 2016 at The Waldorf Astoria New York.
|
| Januray 15, 2016 |
Aurora BioPharma, Inc. to Present Groundbreaking CAR T Therapy Clinical Data in Solid Tumors at NobleCon12 - Noble Financial Capital Markets' 12th Annual Investor Conference
CAMBRIDGE, MA – January 15, 2016 – Aurora BioPharma, Inc., based in Cambridge, Massachusetts, is a private biotechnology company commercializing cutting-edge CAR T cells and therapeutic vaccines combined with checkpoint inhibitors. The Company’s CEO, Robert Brooks, will present its clinical trial data at Club Med in Sandpiper Bay, Florida, on Tuesday, January 19, 2016 at 1:30 pm in Room 3.
|
| January 4, 2016 |
Aurora BioPharma, Inc. to Attend J.P. Morgan Healthcare Conference, and Present at OneMedForum and Biotech Showcase
CAMBRIDGE, MA - January 4, 2016 - Aurora BioPharma, Inc. announces its CEO, Robert Brooks, will attend the 34th Annual J.P. Morgan Healthcare Conference, and present at the following events in San Francisco:
|
| December 15, 2015 |
Aurora BioPharma, Inc. to Present at Biotech Showcase™ during JP Morgan Healthcare Conference
CAMBRIDGE, MA - December 15, 2015 - Aurora BioPharma, Inc., a private immuno-oncology company developing CAR T therapy, vaccines, and checkpoint inhibitors for solid tumors, announces it will present at the Biotech Showcase™ Annual Conference to be held in San Francisco on January 11-13, 2016.
|
| December 15, 2015 |
Aurora BioPharma, Inc. to Present at the Landmark Venture Forum at the Palm Beach Marriott Resort & Spa – Singer Island
CAMBRIDGE, MA - December 15, 2015 - Aurora BioPharma, Inc., a private immune-oncology company developing CAR T therapy, checkpoint inhibitors for solid tumors, announces its CEO, Robert Brooks, will present at the Landmark Venture Forum at the Palm Beach Marriott Resort & Spa – Singer Island on December 15, 2015. This investor, by-invitation only, event will feature presentations from select companies seeking investments.
|
| December 9, 2015 |
Aurora BioPharma, Inc. CEO Meets With Investors at 2015 New England Venture Summit
CAMBRIDGE, MA - December 9, 2015 - The CEO of Aurora BioPharma, Inc., Robert Brooks, will attend the New England Venture Summit taking place December 9th, 2015 at the Hilton Boston Dedham. The illustrious industry gathering is presented by youngStartup Ventures and connects top tier VCs, corporate VCs, venture capitalists, angel investors, university researchers, and incubators.
|
| December 1, 2015 |
Aurora BioPharma, Inc. CEO Meets with Investors at The Family Office Super Summit
CAMBRIDGE, MA - December 1, 2015 - Aurora BioPharma, Inc. announces its CEO, Robert Brooks, will attend The Family Office Super Summit taking place December 1 - 2, 2015 at the JW Marriott Hotel on Brickell Avenue in Miami, Florida. Attendees will join hundreds of private wealth managers, family office executives, and dealmakers for the two-day gathering featuring over 60 speakers. The day is devoted to $1B+ family offices, dozens of single family offices, and hundreds of delegates.
|
| October 12, 2015 |
Aurora BioPharma, Inc. to Present at OktoberINVESTfest 2015
CAMBRIDGE, MA - October 12, 2015 - Aurora BioPharma, Inc. announces its CEO, Robert Brooks, will present at OktoberINVESTfest 2015, the 4th Bavarian American Annual Investors Conference at the New York Academy of Sciences, New York City, Room 2, 2:50 - 3:15 pm EST, on October 13, 2015.
|
| September 24, 2015 |
Aurora BioPharma To Present Promising CAR T Cell Therapy Clinical Data in Glioblastoma at BIO Investor Forum
CAMBRIDGE, MA - September 24, 2015 - Aurora BioPharma, Inc. announces its CEO, Robert Brooks, will present promising CAR T Cell Therapy clinical data in Glioblastoma at the BIO Investor Forum taking place at the Parc 55 Hilton Hotel in San Francisco on October 20-21, 2015.
|
| September 16, 2015 |
Aurora BioPharma, Inc. Attends RESI Boston 2015
CAMBRIDGE, MA - September 16, 2015 - Aurora BioPharma, Inc. announces its participation at the Redefining Early Stage Investments (RESI) Boston 2015 conference. The event will be held at The Westin Copley Place in Boston, MA, on September 16, 2015. Life Science Nation (LSN) will be hosting the gathering in collaboration with Johnson & Johnson Innovation, JLABS (JLABS). The RESI conference attracts Corporate Venture Capital Funds, Family Offices, Venture Philanthropy Funds, VCs, and Angel groups. The event serves as an opportunity for fundraising executives to identify and meet life science investors. The goal is to develop new medical breakthroughs in the discovery of advanced technologies and cancer immunotherapies.
|
| September 7, 2015 |
Aurora BioPharma, Inc. CEO to Attend the Rodman & Renshaw 2015 Annual Global Investment Conference
CAMBRIDGE, MA - September 7, 2015 - Aurora BioPharma, Inc. announces that its Chief Executive Officer, Robert Brooks, will attend the Rodman & Renshaw 17th Annual Global Investment Conference taking place at the St. Regis Hotel in New York City on September 8 - 10.
|
| August 24, 2015 |
Aurora BioPharma, Inc. CEO Attends The Annual ImVacS
CAMBRIDGE, MA - August 24, 2015 - Aurora BioPharma, Inc. announces that its Chief Executive Officer, Robert Brooks, will attend the 10th Annual ImVacS: Immunotherapy and Vaccine Summit on August 24 - 28, 2015 in Boston, Massachusetts presented by the Cambridge Healthtech Institute. The event attracts over 300 international delegates from biotech and pharma every year. This year's gathering will cover vaccine, immunotherapy technologies, immunomodulatory therapeutic antibodies for cancer, combination cancer immunotherapy and others. ImVacS 2015 promises to be a prominent gathering for academic and healthcare professionals in the advancement of immunotherapies and vaccines through innovation.
|